PureTech Health plc (PRTC) — Institutional Holders, Q1 2026
5 institutional investment managers reported a PRTC position on SEC Form 13F-HR for the quarter ended March 31, 2026, with a combined reported value of $2.0M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PRTC in Q1 2026: what funds did
Funds that filed a 13F for both Q4 2025 and Q1 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
New positions
0
Added to
2
Trimmed
0
Sold out
0
Biggest buyers
- MILLENNIUM MANAGEMENTAdded · +44,090 sh+$654.7K
Biggest sellers
None this quarter.
PRTC 13F holders ranked 1–5 of 5
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q4 2025 |
|---|---|---|---|---|---|
| 1 | Pentwater Capital Management#1 · 70,000 sh | 70,000 | $1.0M | — | 0.0% |
| 2 | MILLENNIUM MANAGEMENT#2 · 59,525 sh | 59,525 | $882.8K | — | +285.6% |
| 3 | Persistent Asset Partners Ltd#3 · 1,759 sh | 1,759 | $26.1K | — | 0.0% |
| 4 | DIADEMA PARTNERS#4 · 7,924 sh | 7,924 | $11.3K | — | +6.5% |
| 5 | UBS Group AG#5 · 20 sh | 20 | $297.00 | — | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q1 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q4 2025 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.